MOBILE, Ala.--(BUSINESS WIRE)--CPSI (NASDAQ: CPSI), a healthcare solutions company, today announced that the Company and PointClickCare, a leading healthcare technology...
STOCKHOLM, SWEDEN / ACCESSWIRE / January 17, 2024 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO:ALZCUR), a pharmaceutical...
ApolloMD C-Suite Announces New Leadership Roles in 2024ATLANTA, GA / ACCESSWIRE / January 17, 2024 / ApolloMD, a leading national...
Study real-world outcomes of IBD infliximab patients with the Anser TDM Test: Presentation by Prometheus using the Lynx GI data...
New report commissioned by Blue Cross and Blue Shield of Minnesota exposes the ramifications of smoking on health and the...
MOBILE, Ala.--(BUSINESS WIRE)--CPSI (NASDAQ: CPSI), a healthcare solutions company, today announced that the Company has divested its subsidiary, American HealthTech,...
This collaboration will boost access and integration with best-in-class autonomous medical coding for healthcare providers.SAN FRANCISCO--(BUSINESS WIRE)--#AutonomousMedicalCoding--Fathom, the leader in...
DermaSensor Now Available to Improve Skin Cancer Detection in Primary CareMIAMI--(BUSINESS WIRE)--DermaSensor Inc. announces FDA clearance for its real-time, non-invasive...
Dr. Kimmel brings more than 15 years of leadership to AMC HealthNEW YORK, NY / ACCESSWIRE / January 17, 2024...
TORONTO and HAIFA, Israel, Jan. 17, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (FSE: J90) (NRX.V) (the “Company”...
INVO (NASDAQ: INVO) and NAYA Biosciences expect to close their previously announced merger in the first quarter of 2024Experienced, entrepreneurial leadership...
BRISBANE, Calif., Jan. 17, 2024 (GLOBE NEWSWIRE) -- Day One Biopharmaceuticals (Nasdaq: DAWN) (“Day One” or the “Company”), a clinical-stage...
Nociscan is the first augmented intelligence platform to measure pain biomarkers in the lumbar spine This new product release expands...
TORONTO, Jan. 17, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ: VERO), a global medical...
Financing was led by New Enterprise Associates (NEA) and closed with additional new investor Atlas Venture and continued investment by...
Report highlights latest biosimilar pricing and market share status, including state of the adalimumab marketBiosimilar Deep Dive section illustrates patient...
The Combined Company Is Expected To Trade On Nasdaq Post-Closing Under A New Ticker SymbolMediforum is a leading biotechnology company...
GENEVA, SWITZERLAND / ACCESSWIRE / January 17, 2024 / With cancer projected to escalate to 29 million cases by 2040,...
Further Data Confirms POLB 001's Potential in Cancer Immunotherapy-Induced Cytokine Release Syndrome (CRS)Market opportunity estimated to be greater than US$1...
Rebranding tied to its popular workflow automation solution by the same nameHUNTINGTON BEACH, Calif.--(BUSINESS WIRE)--Voluware formally reintroduces itself today as...